IJH Volume 122, Issue 1, July 2025 is now available. JSH members can access the full text. Association between gene mutations and outcomes in Japanese high-risk AML patients: a phase 1/2 study of NS-87/CPX-351 Effects of tucidinostat in adult T-cell leukemia/lymphoma in clinical practice Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE study Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era and more!
